Today is November 2, 2009, stock index of gold wire at 2997 points, ended last week in the gold line, hold out the broader market neutral trading day 2, once again U.S. stock market plunge last Friday, but Friday was the domestic GEM stir into the hot money, we think the result is the collapse stir today, though not necessarily all the limit, but we think there will be 1-2 down limit of the stock appears. So today we look at limit down the main drag today, 3003 / 3029/3055/3087 point, support 2977/2951/2928/2901 point.
Xi'an speech: Where is the broader market fell to hunters?
9: 11 Friday in the GEM can be considered linked to limit-down price auction to sell . because some stocks will pull up, it is recommended that reference to company performance, it is promising high-growth stocks may be pulled from the down limit daily limit, so the comments only for reference, depends on the individual stocks.
9:30 broader market to open lower, will be rebound, the GEM group almost daily limit is spectacular.
9:34 opening point is supported.
9:40 will receive the approval of Shanghai rumors of Disney, the Shanghai local related stocks stronger.
9:43 Last week we dig in the biopharmaceutical and animal vaccines adjustment plate again another new high strength .600201, gold line, we do not participate.
9:46 back down again, support 2929.
9:50 to support near the bounce.
9:55 broader market quickly rebounded, animal vaccines plate inside 600 195 600 201 research reports have become the leading rally, the market no one is digging-reviewed. the concept of things, bio-pharmaceutical sector is ahead of us and warning.
10:04 pharmaceutical stocks is expected to become one of the multi-year investment themes, and influenza A H1N1 influenza epidemic situation is accelerating rapidly rising stock market, medical degree, so we believe that the reorganization of the pharmaceutical sector, performance and stability composite concept of pharmaceutical stocks is worth studying. such as:
1. Tianmu Pharmaceutical (600671) bio-pharmaceutical industrial park: Huangshan Tianmu pharmaceutical and biotech industrial park by the pharmaceutical, biotechnology, health care products and R & D center composed of four major forum, One phase of the project R & D center for the pharmaceutical and the two section. Industrial Park, construction of the basic idea is: high-tech, export-oriented, intensive. Company intends to invest in the size of 1,500 acres of demonstration of Dendrobium GAP planting base. company and the Chinese Academy of Sciences of genetic Eye of the joint venture of Compass Biological Pharmaceutical Co., Ltd. (companies accounted for 72% shares) developed freeze-dried mouse epidermal growth factor. Although three quarters of a loss, but a closer look, because the result into a larger market, that means that once sales stability, performance undoubtedly played a significant role in the published results also mean advantage of this opportunity is a concern.
2. Jianfeng Group (600,668) combined central enterprises, integration of regional cement: The company is the largest cement Zhejiang production enterprises. pharmaceutical business: the company's pharmaceutical business, a variety of dosage forms of 18 production lines have been the GMP certification, pre-new drug to market: Cefmenoxime hydrochloride for injection, etc. After years of market development, profitability has become a major varieties; focus on the development of the two types of drugs, three quarterly disclosure, the company from January to September net profit of 38.467 million yuan, net profit rose 143.88%, the future worth looking forward to.
3. Double Heron Pharmaceutical (002038) is China's pharmaceutical industry is the backbone of genetic engineering enterprises, the main business of cancer, cardiovascular and cerebrovascular diseases, hepatitis, organ transplantation of genetically engineered medicine, chemistry, Shenghua Yao's R & D .09 years of Disclosure in the past three years, net profit compound growth rate of 86.06%, 08 sample survey of hospitals in a nationwide sample sales of specialty drugs ranked 21 companies (including foreign investment, joint ventures and domestic enterprises), to elevate the overall strength of the company on April .09 company transferee 38.872 million yuan in cash held in Hainan Medical City of Victoria Some 17.2% stake Beijing Puren hung. Puren Hong existing customers more than 120 medical institutions, dozens of exclusive varieties, agents operating more than 300 manufacturers were more than a thousand varieties of species. As a high-end focus on Beijing pharmaceutical market in the pharmaceutical logistics distribution of large commercial enterprises, is currently in Beijing Puren Hospital, Hong medication largest private enterprises in the market drug distribution company. marketing network covers more than two hospitals in Beijing all the .08 net profit of 31,337,800 yuan in expected 2009 net profit growth will remain above 30%, optimistic about the future.
4. Humanwell Technology (600079) biomedical concepts: the company holding 70% of the Yichang blessing medicine is the first point, one of the production of narcotic drugs , has called Development and Reform Commission has been included in the national high-tech industrialization demonstration projects, production and operation of 208 varieties, quality formulations and bulk drugs regulation, has the exclusive production of raw materials and formulations of fentanyl citrate, citrate national three new drugs sufentanil raw materials and preparations. worthy of attention.
above study was only based on the main market funds to study the idea of digging, I hope you learn by analogy, always grasp the context, so the market winner
10:04 from the current market Look, the bottom broader market rebounded today, mainly, will receive a fake Yang Xian (closed points higher than the opening point), but overall performance is down, so if there meteoric rise, the proposal to lighten up heavy positions.
Today is 2009 on November 2, Gold Line stock index points in 2997, closed last week at the gold line, hold out the broader market neutral trading day 2, once again U.S. stock market plunge last Friday, but Friday was hot money explosive domestic GEM speculation, we believe that the result is the collapse stir today, though not necessarily all the limit, but we think there will be 1-2 down limit of the stock appears. So today we look at limit down the main drag 3003/3029/3055 today / 3087 points, support 2977/2951/2928/2901 point.
Xi'an speech: Where is the broader market fell to hunters?
9:11 on Friday in the GEM can be considered linked to limit-down price auction to sell. As some of the stocks will pull up, it is recommended that reference to company performance, it is promising high-growth stocks may be pulled from the down limit daily limit, so the comments only for reference, depends on the individual stocks.
9:30 broader market to open lower, rebound, entrepreneurship Almost daily limit is spectacular collective plate.
9:34 opening point is supported.
9:40 will receive the approval of Shanghai rumors of Disney, the Shanghai local related stocks stronger.
9:43 last week we Mining sector biopharmaceutical and animal vaccines to adjust again another new high strength .600201, gold line, we do not participate.
9:46 back down again, support 2929.
9:50 to rally support around.
9:55 broader market quickly rebounded, animal vaccines plate inside 600 195 600 201 research reports have become the leading rally, the market no one is digging-reviewed. the concept of things, bio-pharmaceutical sector is ahead of us, and early warning. < br> 10:04 pharmaceutical stocks are expected to become a multi-year investment in one of the themes, and influenza A H1N1 influenza epidemic situation is accelerating rapidly rising stock market, medical degree, so we believe that the reorganization of the pharmaceutical sector, performance and stability, complex concept pharmaceutical stock worth studying. as:
1. Tianmu Pharmaceutical (600671) bio-pharmaceutical industrial park: Huangshan Tianmu pharmaceutical and biotech industrial park by the pharmaceutical, biotechnology, health care products and R & D centers such as the four Forum, of which one Engineering R & D center for the pharmaceutical and the two section. Industrial Park, construction of the basic idea is: high-tech, export-oriented, intensive. Company intends to invest in the size of 1,500 acres of demonstration of Dendrobium GAP planting base. the company established a joint venture with the Chinese Academy of Sciences of Genetics, The biopharmaceutical Eye Compass Limited (72% shares of the company) to develop a freeze-dried mouse epidermal growth factor. Although three quarters of a loss, but a closer look, because the result into a larger market, that means that once the sale of stability, undoubtedly play a significant role in performance, the published results have advantage of this opportunity means a cause of concern.
2. Jianfeng Group (600,668) combined central enterprises, integration of regional cement: The company is the largest cement producer in Zhejiang enterprises. pharmaceutical business: the company's pharmaceutical business, various formulations of a total of 18 production lines have been the GMP certification, pre-new drug to market: Cefmenoxime hydrochloride for injection, etc. After years of market development, profitability has become a major varieties; focus on the development of two types of new drugs, disclosure, the company from January to September net profit of 38.467 million yuan, net profit rose 143.88%, the future worth looking forward to.
3. Double Heron Pharmaceutical (002038) is the genetic engineering of the backbone enterprises of the pharmaceutical industry, the main business operations for cancer, cardiovascular disease, hepatitis, organ transplantation of genetically engineered medicine, chemistry, Shenghua Yao's R & D .09 years of Disclosure in the past three years, net profit compound growth rate of 86.06%, 08 samples of domestic sample survey of hospital sales specialist drug company ranked 21 (including foreign investment, joint ventures and domestic enterprises), to elevate the overall strength of the company on April .09 company transferee 38.872 million yuan in cash held in Beijing, Hainan Medical City of Victoria Puren 17.2% stake Hung. Puren Hong existing customers more than 120 medical institutions, dozens of exclusive varieties, agents operating more than 300 manufacturers were more than a thousand varieties of species. as a focus on high-end medical market in Beijing Medical logistics and distribution of large commercial enterprises, is currently in Beijing Puren Hospital, Hong medication largest private enterprises in the market drug distribution company. marketing network covers more than two hospitals in Beijing all the .08 net profit of 31,337,800 yuan on expected 2009 net more than 30% profit growth will be maintained, the future promising.
4. Humanwell Technology (600079) biomedical concepts: the company holding 70% of the Yichang blessing medicine is the first point, one of the production of narcotic drugs, has been as the Commission included in the national high-tech industrialization demonstration projects, production and operation of 208 varieties, quality formulations and bulk drugs regulation, has the exclusive production of raw materials and formulations of fentanyl citrate, the state three new drugs too citrate Shufen Nigerian raw materials and preparations. worthy of attention.
above study was only based on the main market funds to study the idea of digging, I hope you learn by analogy, always grasp the context, so the market winner
10:04 from the current market, today the broader market dominated by bottom bounce, will receive a fake Yang Xian (closed points higher than the opening point), but overall performance is down, so if there meteoric rise, the proposal to lighten up heavy positions.
10:21 broader market continued to rebound . resistance near the 2977. disinfection of the concept of 600,315 performed well.
10:33 broader market decline, a rebound goal is to support a 2955.10:43 meteoric rise, meteoric rise to lighten up after the note.
10:52 now sell more than buy volume, but also shock.
11:02 broader market turmoil, bounced back to near the line is still the gold to lighten up.
11:09 meteoric rise to broader market will be.
11:11 well, meteoric rise, and Our prompt attention to the plate on Friday in a rebound may be appropriate to lighten up.
11:25 on the 3000 tape, but we still think that is down relay, the afternoon will be adjusted, but does not affect the income Yang Xian today. < br>
No comments:
Post a Comment